benazepril, Lotensin (cont.)Pharmacy Author:
Omudhome Ogbru, PharmD
Omudhome Ogbru, PharmDDr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99. Medical and Pharmacy Editor:
William C. Shiel Jr., MD, FACP, FACR
William C. Shiel Jr., MD, FACP, FACRDr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology. PREGNANCY: ACE inhibitors, including benazepril, can be harmful to the fetus and should not be taken by pregnant women. NURSING MOTHERS: A small amount of benazepril is excreted into breast milk. A newborn exclusively breastfed may ingest less than 0.1% of the maternal dose of benazepril. SIDE EFFECTS: Benazepril is generally well tolerated and side effects are usually mild and transient. Side effects include abdominal pain, constipation, diarrhea, dizziness, fatigue, headache, loss of taste, loss of appetite, nausea and vomiting, easy bruising or bleeding, chest pain, chills, difficulty breathing, severe dizziness or fainting, fever, numbness or tingling in the hands or feet, rash, impotence, and a sore or swollen throat. A dry, persistent cough has been reported with the use of benazepril and other ACE inhibitors. Coughing resolves after discontinuing the medication. In rare instances, liver dysfunction and skin yellowing (jaundice) have been reported with ACE inhibitors. Benazepril should not be taken by people with a known allergy to ACE inhibitors. Swelling of the facial tissues and even the upper airways has been reported with ACE inhibitors on very rare occasions, and can lead to serious breathing difficulties. In rare instances, low white blood cell counts have been reported with the use of one ACE inhibitor. Low white blood cells increase the patient's risk of infections. Reference: FDA Prescribing Information Last Editorial Review: 2/24/2012
Back to Medications Index |
Get the latest health and medical information delivered direct to your inbox FREE!


